JPRN-UMIN000048984招募中2 期
Feasibility study of hyperthermic treatment by ASKIRF-8 for solid tumors - Feasibility study of hyperthermic treatment
Matsunami General Hospital Division of Hematology and Medical Oncology0 个研究点目标入组 30 人开始时间: 2022年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Ophthalmological cancer and brain tumors 2.Hematological malignancies 3.Metal in around the treatment region
研究者
相似试验
尚未招募
1 期
TO CHECK THE SAFETY OF WARM CHEMOTHERAPY FOR ADVANCED ORAL CANCERSCTRI/2024/04/065397Tata Memorial Centre
已完成
1 期
Phase I/II Trial of a novel mild hyperthermia using Oncothermia (EHY-2000) and TS-1/Docetaxel in the treatment of peritoneal metastatic gastric cancerGastric cancerJPRN-UMIN000022420Chiba University33
已完成
不适用
Phase one clinical trials of hyperthermia using radiofrequency capacitive heating device and magnetic cationic liposome in prostate cancer resistant to standard treatmentprostate cancerJPRN-UMIN000021187agoya City University Hospital3
进行中（未招募）
不适用
_Ovarian epithelial cancer : intraperitoneal resectable relapseMedDRA version: 17.1Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023035-42-ITICANCER
进行中（未招募）
不适用
Randomized phase III study evaluating hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapseOvarian epithelial Cancer: intraperitoneal resectable relapseMedDRA version: 14.1Level: PTClassification code 10033160Term: Ovarian epithelial cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023035-42-ESnicancer444